中国成人2 型糖尿病hba1c 控制目标的专家共识解析.pdfVIP

2011 2 31 2 113 2HbA c 1 曹明明,童南伟 : 1005- 2194( 2011) 02- 0113- 03 : 5 : A : 血糖控制是延缓糖尿病进展及并发症的重要措施之一, 但 个体化的糖化血 蛋白 (HbA c)控制 1 目标值在不同的患者究竟如何还存在分歧为了满足中国糖尿病治疗工作的需要, 中华医学会内分泌学 分会组织相关专家, 对中国成人 2型糖尿病HbA c控制目标提出了初步共识: 不统一推荐成人 2型糖尿病 1 的 HbA c控制目标, 从病情分层和社会因素的差异建议相对较合理的 HbA c值强调血糖控制必须安 1 1 全可行科学, 坚持 个体化原则,其中安全性最重要同时强调血糖之外的其他血管病危险因素的控制也 十分重要 : 2型糖尿病;糖化血 蛋白 Interp re tation of Chinese Society of Endocrino logy ( 2010) consensu s statem en t on H bA1 c con trol target in adu lts w ith type 2 d iabe tes in Ch ina. CAO M ingm ing, TONG N anwei. Division of Endocrinology and M etabolism, West China osp ital of Sichuan University, Chengdu 610041, China Summ ary: G lycem ic control is one of the mi portant treatments for delaying the progression and complications in diabetes, but divergences exist on the individualHbA c control target of different patients. A prelmi inary con 1 sensus on theHbA c control target in adultsw ith type 2 diabetes is proposed by experts ofChinese Society ofEn 1 docrinology( CSE). Instead of recommending a general standard value for all patients, a reasonable target is sug gested to satisfy the different conditions and social factors. Some mi portant principlesmust be followed for the gly cemic control, including safety, feasibility, scientificity and individualization; among which, the most mi portant one is safety. Besides, to control plasma glucose, we should pay equalattention to the other risk factors ofvascular dis ease at the same tmi e. K eyw ord s: type 2 diabetes; HbA c